Details of the Drug

General Information of Drug (ID: DME0XSP)

• Drug Name: STI-001
• Synonyms: AP4-24H11; STI-001 program (mAbs targeting S aureus auto-inducing peptides); Fully human anti-AIP monoclonal antibody (MRSA/bacterial infections), Sorrento Therapeutics; Quorum sensing-targeting antibodies (MRSA/bacterial infections), Sorrento Therapeutics; STI-001 program (mAbs targeting S aureus auto-inducing peptides), Sorrento Therapeutics

Indication

Disease Entry	ICD 11	Status	REF
Colorectal cancer	2B91.Z	Phase 3	[1]
Bacterial infection	1A00-1C4Z	Investigative	[2]

• Cross-matching ID: TTD ID: D0D1UD
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.